asthma action plan

Asthma action plan

The key to asthma management

Whether your asthma is mild or severe, it’s important to have an asthma action plan.

An asthma action plan describes how to manage your asthma. It includes information about your asthma medications, including:
    Your asthma controller medication:
  • What medicine it contains
  • How much to take
  • When to take it
The asthma action plan also includes information about what to do if you are having a serious asthma attack or need emergency treatment. Be sure to personalize the plan with the help of your healthcare provider.

Download an asthma action plan here.



ProAir® HFA (albuterol sulfate) Inhalation Aerosol is indicated in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

Important Safety Information

If your symptoms become significantly worse when you use ProAir® HFA, contact your doctor immediately. This may indicate either a worsening of your asthma or a reaction to the medication, which may rarely occur with the first use of a new canister of ProAir® HFA. Either of these could be life-threatening.

What to tell your doctor before using ProAir® HFA: If you have a heart, blood, or seizure disorder, high blood pressure, diabetes, or an overactive thyroid, be sure to tell your doctor. Also make sure your doctor knows all the medications you are taking – especially heart medications and drugs that treat depression – because some medications may interfere with how well your asthma medications work. Do not exceed the recommended dose.

Side effects associated with ProAir® HFA included headache, rapid heart beat, pain, dizziness, and irritation of the throat and nose.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
©2011 Teva Respiratory, LLC. This site is intended for U.S. residents only. All Rights Reserved.
ProAir® HFA is a registered trademark of Teva Respiratory, LLC.
EIB Active™ is a trademark of Teva Respiratory, LLC. EIB Active™ is sponsored by Teva Respiratory.
Brooke Sydnor Curran is a paid spokesperson for Teva Respiratory.
111440